COMMUNIQUÉS West-GlobeNewswire

Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Promising New Gene Therapies
09/05/2019
NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “New Gene Therapies Hold Out Promise for Patients.” To [...]
Fluidigm to Participate in Upcoming Health Care Investor Conferences
09/05/2019
SOUTH SAN FRANCISCO, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced [...]
Crown Bioscience Announces San Diego, CA Site Expansion
09/05/2019
International Center of Excellence for oncology biomarker and inflammation translational services created SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services [...]
Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2019
09/05/2019
Bagsværd, Denmark, 9 May 2019 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of [...]
ChromaDex Announces $10 Million Issuance of Convertible Notes
09/05/2019
Private Placement Led by High Profile Venture Capitalists and Strategic Investors LOS ANGELES, May 09, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that it has entered into a note purchase [...]
Better Choice Company Continues Expansion into Latin America through MOU for Supply of CBD in Uruguay
09/05/2019
NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc (OTCQB: BTTR) (the “Company”) is pleased to announce that it has signed a memorandum of understanding (“MOU”) with Terrace Inc. (“Terrace”) for the [...]
Avid Bioservices Reaffirms Fiscal 2019 Guidance and Announces Upcoming Conference Participation
09/05/2019
TUSTIN, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
American Autism and Rehabilitation Center selects Allscripts to provide revenue cycle management solution
09/05/2019
Organization signs seven-year agreement to elevate its billing cycle process to an end-to-end revenue cycle management solution CHICAGO, May 09, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) announced today that [...]
Innovate Biopharma Announces Analyst Event on Monday, May 20, 2019, in San Diego
09/05/2019
RALEIGH, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for immuno-inflammatory [...]
Fibrocell to Host Conference Call and Webcast on Wednesday, May 15, 2019 to Discuss First Quarter 2019 Financial Results and Recent Operational Highlights
09/05/2019
EXTON, Pa., May 09, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, will [...]
Spectral Announces First Quarter Results
09/05/2019
TORONTO, May 09, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT) , a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its [...]
resTORbio Announces Initiation of Phase 3 Clinical Program of RTB101 in Clinically Symptomatic Respiratory Illness
09/05/2019
Top-line data from both PROTECTOR Phase 3 studies expected in mid-2020 BOSTON, May 09, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), today announced the initiation of PROTECTOR 1, the first Phase 3 trial of [...]
Agile Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare Conference
09/05/2019
PRINCETON, N.J., May 09, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today that its Chairman and Chief Executive Officer, Al Altomari, will present at the [...]
Chimerix Announces First Quarter 2019 Financial Results and Strategy Update
09/05/2019
– Reports Positive Top-line Survival Data from Pivotal Mouse Study as Key Milestone on Path to Smallpox Regulatory Submission – – Plan to Focus on Execution of Smallpox Program, Halting All Other Brincidofovir [...]
Merus Announces First Patient Treated in Phase 1 Clinical Trial of MCLA-145 for Advanced Solid Tumors
09/05/2019
UTRECHT, Netherlands, May 09, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human bispecific antibody therapeutics, today [...]
Momenta Pharmaceuticals to Webcast Presentation at the 2019 Bank of America Merrill Lynch Healthcare Conference
09/05/2019
CAMBRIDGE, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated [...]
Atara Biotherapeutics Announces First Quarter 2019 Financial Results and Recent Operational Progress
09/05/2019
SOUTH SAN FRANCISCO, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Dr. Anish Suri, Cue Biopharma’s CSO, to Participate in Panel Discussion at Upcoming NYAS Frontiers in Cancer Immunotherapy Conference
09/05/2019
Overview and Update on the Immuno-STAT Platform for Selective Targeting of Tumor-specific T cells CAMBRIDGE, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy [...]
Selecta Biosciences Reports First Quarter 2019 Financial Results and Provides Corporate Update
09/05/2019
- Patient enrollment ongoing in COMPARE trial evaluating efficacy and safety of SEL-212 vs. KRYSTEXXA® in patients with chronic refractory gout; interim data expected in 4Q19 - - Preclinical data showing potential for [...]

Pages